ReportsnReports

ReportsnReports-Lifesciences IT - 2011 Yearbook

ReportsnReports adds GBI Research’s ‘Power Market in Western Europe to 2020 - Government Policies Downplaying the Nuclear Energy Industry and Spurring the Growth of Renewable Energy’ to its store.

ReportsnReports:Power Market in Western Europe to 2020 - Government Policies Downplaying the Nuclear Energy Industry and Spurring the Growth of Renewable Energy

GBI Research’s report, “Power Market in Western Europe to 2020 - Government Policies Downplaying the Nuclear Energy Industry and Spurring the Growth of Renewable Energy” provides an in-depth analysis of the power market of the top 12 Western European countries (France, Germany, Austria, The United Kingdom, Spain, The Netherlands, Switzerland, Sweden, Norway, Italy, Portugal and Belgium). The report provides deep insights and emerging trends in the power market for each country, with detailed forecast of the installed capacity and generation by thermal, hydro, renewable (solar PV, biomass, wind etc.) and nuclear sources up to 2020.

ReportsnReports- Opioids Market to 2017 - Steady Uptake of Oxycontin and High Incidence of Diseases Such As Cancer and Arthritis to Drive the Market

GBI Research, the leading business intelligence provider, has released its latest research, “Opioids Market to 2017 - Steady Uptake of Oxycontin and High Incidence Of Diseases Such As Cancer And Arthritis to Drive the Market”, which provides insights into global opioids market and market forecast until 2017. The report provides an in-depth analysis of the top seven therapeutic indications for which often opioids are prescribed which includes fibromyalgia, neuropathic pain, cancer pain, osteoarthritis pain, rheumatoid arthritis pain, low back pain and post operative pain. The report also examines the global opioids treatment usage patterns for the covered indication. In addition, the report also includes insights into the opioids R&D pipeline.

ReportsnReports – Daptomycin- Comprehensive Patent Search

ReportsnReports.com adds MarketsAndMarkets Market Research Report ‘Pralatrexate- Comprehensive patent search ’ to its store.

ReportsnReports – Ixabepilone – Comprehensive Patent Search

ReportsnReports.com adds MarketsAndMarkets Market Research Report ‘Ixabepilone - Comprehensive patent search ’ to its store.

ReportsnReports – Pralatrexate- Comprehensive patent search

ReportsnReports:Time and Cost Reduction in Clinical Trials- Outsourcing and IT to Optimize Patient Recruitment, Logistics, Data and Site Management

GlobalData, the industry analysis specialist, has released its new report, “Human Papillomavirus (HPV) Therapeutics – Pipeline Assessment and Market Forecasts to 2017”. The report is an essential source of information and analysis on the global Human Papillomavirus (HPV) Therapeutics market. The report identifies the key trends shaping and driving the global Human Papillomavirus (HPV) Therapeutics market.

ReportsnReports- Top 10 Emerging Oil Storage Markets – Analysis, Competitive Landscape

With the advent of issue of energy security, the oil storage industry globally, is gaining importance. Increasing need for energy security and higher domestic demand for oil and refined products are encouraging more countries across the globe to increase their storage capacity infrastructure to tide over supply disruptions or sudden price hikes. Even smaller countries like Vietnam, Maldives, etc are adding storage capacities aggressively.

Human Papillomavirus (HPV) Therapeutics – Pipeline Assessment and Market Forecasts to 2017

GlobalData, the industry analysis specialist, has released its new report, “Human Papillomavirus (HPV) Therapeutics – Pipeline Assessment and Market Forecasts to 2017”. The report is an essential source of information and analysis on the global Human Papillomavirus (HPV) Therapeutics market. The report identifies the key trends shaping and driving the global Human Papillomavirus (HPV) Therapeutics market.

ReportsnReports – Brazil Biomaterial Market (2010 – 2015)

The Brazil market for biomaterials is expected to reach $1.7 billion in 2015 from $550.2 million in 2008 with a CAGR of 19.5% from 2010 to 2015. In 2009, the orthopedic biomaterial market recorded revenues of $236.5 million or 37.5% of the total biomaterial products market. This is mainly because of increasing application areas and introduction of sophisticated technologies in the biomaterials market. However, the orthopedic biomaterial market is estimated to grow at a CAGR of 17.2% from 2010 to 2015. Cardiovascular biomaterial products market is the second-highest market, contributing 36% of the total biomaterial products market.